Literature DB >> 9801894

Rapid isolation of choriocapillary endothelial cells by Lycopersicon esculentum-coated Dynabeads.

S Hoffmann1, C Spee, T Murata, J Z Cui, S J Ryan, D R Hinton.   

Abstract

In vitro studies of choroidal endothelial cells may be critical for understanding the pathogenesis of neovascularization in age-related macular degeneration, since endothelial cells from different sites are highly heterogeneous in their morphology and behavior. Isolation of choroidal endothelial cells is complicated and labor intensive because of the small size of the choroid and the difficulty of excluding contaminating cells. We describe a rapid, simplified method for the isolation of bovine choroidal endothelial cells using microdissection followed by the use of superparamagnetic beads (Dynabeads) coated with the endothelial cell-specific lectin Lycopersicon esculentum, which selectively binds to fucose residues on the endothelial cell surface. Cells bound to beads are isolated using a magnetic particle concentrator. Isolated cells grew to confluence in a monolayer with a cobblestone morphology and were shown to be endothelial cells by their greater than 95% immunoreactivity to von Willebrand factor and phagocytosis of dil-acetylated LDL. Isolated cells grew as tubes in three-dimensional cultures. This method markedly reduces the time needed for pure culture of cells and makes the in vitro study of choroidal endothelial cells practical and reproducible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801894     DOI: 10.1007/s004170050158

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  13 in total

1.  Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Authors:  M S Spitzer; B Wallenfels-Thilo; A Sierra; E Yoeruek; S Peters; S Henke-Fahle; K U Bartz-Schmidt; P Szurman
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

2.  Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

Authors:  Swaantje Peters; Sylvie Julien; Peter Heiduschka; Salvatore Grisanti; Focke Ziemssen; Martin Adler; Ulrich Schraermeyer; Karl-Ulrich Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

3.  An in vitro model for studying vascular injury after laser microdissection.

Authors:  Keiko Fujita; Kumiko Komatsu; Kayoko Tanaka; Susumu Ohshima; Yoshiko Asami; Eiko Murata; Masumi Akita
Journal:  Histochem Cell Biol       Date:  2005-11-16       Impact factor: 4.304

4.  Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells.

Authors:  Stephan Hoffmann; Stephanie Balthasar; Ulrike Friedrichs; Marianne Ehren; Stephen J Ryan; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-09       Impact factor: 3.117

5.  PEDF expression affects the oxidative and inflammatory state of choroidal endothelial cells.

Authors:  Mitra Farnoodian; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-10       Impact factor: 4.249

6.  Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye.

Authors:  Irina Semkova; Florian Kreppel; Gerhard Welsandt; Thomas Luther; Jolanta Kozlowski; Hanna Janicki; Stefan Kochanek; Ulrich Schraermeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

7.  [Carboxyamido-triazole inhibits substeps of choroidal neovascularization on retinal pigment epithelial cells and choroidal endothelial cells in vitro].

Authors:  S Hoffmann; S He; P Wiedemann
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

8.  An in vitro model of the back of the eye for studying retinal pigment epithelial-choroidal endothelial interactions.

Authors:  Wei Fan; Jing Juan Zheng; Barbara J McLaughlin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-04       Impact factor: 2.416

9.  Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.

Authors:  Martin S Spitzer; Efdal Yoeruek; Ana Sierra; Barbara Wallenfels-Thilo; Ulrich Schraermeyer; Bernhard Spitzer; Karl U Bartz-Schmidt; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

10.  Attenuation of choroidal neovascularization by histone deacetylase inhibitor.

Authors:  Nymph Chan; Shikun He; Christine K Spee; Keijiro Ishikawa; David R Hinton
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.